‘Inlyta’ applied to national health insurance service this July

‘Inlyta Tab,’ a targeted therapy for renal cancer, will be applied to the national health insurance service this July.

Drug prices of Simponi, a rheumatoid arthritis therapy, and Soliris, a paroxysmal nocturnal hemoglobinuria(PNH) therapy, will get cut due to extended indications.

The Ministry of Health and Welfare(MOHW) revised and announced the ‘Drug Insurance Benefit List and Upper Limit P...